Farther Finance Advisors’s ProPhase Labs PRPH Stock Holding History

Farther Finance Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	10	–	–	﹤0.01%	5973
2026 Q1	$1	Buy	10 +1	+11%	–	﹤0.01%	5747
2025 Q4	$4	Sell	9 -1	-10%	-$3	﹤0.01%	5430
2025 Q3	$44	Hold	10	–	–	﹤0.01%	4876
2025 Q2	$38	Hold	10	–	–	﹤0.01%	4389
2025 Q1	$39	Hold	10	–	–	﹤0.01%	4146
2024 Q4	$73	Hold	10	–	–	﹤0.01%	3834
2024 Q3	$235	Hold	10	–	–	﹤0.01%	3613
2024 Q2	$394	Hold	10	–	–	﹤0.01%	3328
2024 Q1	$664	Hold	10	–	–	﹤0.01%	2929
2023 Q4	$438	Hold	10	–	–	﹤0.01%	3011
2023 Q3	$424	Hold	10	–	–	﹤0.01%	2312
2023 Q2	$704	Hold	10	–	–	﹤0.01%	2056
2023 Q1	$739	Hold	10	–	–	﹤0.01%	1910
2022 Q4	$934	Buy	+10	New	+$1.08K	﹤0.01%	1671

Other funds holding PRPH

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Farther Finance Advisors's PRPH Position: Q2 2026 in Review

Farther Finance Advisors held its ProPhase Labs (PRPH) position steady in Q2 2026 at 10 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5973.

Farther Finance Advisors first reported a position in PRPH in Q4 2022 and has held it in 15 quarters since. The position peaked at $934 in Q4 2022. 2 funds tracked by Wall St. Rank hold PRPH as of Q2 2026.

Farther Finance Advisors held 10 shares of ProPhase Labs worth $1 as of Q2 2026.
Farther Finance Advisors left its ProPhase Labs share count unchanged in Q2 2026.
ProPhase Labs made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5973 holding.
Farther Finance Advisors first reported a position in ProPhase Labs in Q4 2022 and has held it in 15 quarters since.
Farther Finance Advisors's ProPhase Labs position peaked at $934 in Q4 2022.
2 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.